Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients
Authors:
- 29 March 2012
- journal article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 16 (5) , 779-785
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Vitamin D Biology: From the Discovery to Its Significance in Chronic Kidney DiseaseJournal of Renal Nutrition, 2011
- Chronic kidney disease, hypovitaminosis D, and mortality in the United StatesKidney International, 2009
- Vitamin D as a Novel Nontraditional Risk Factor for Mortality in Hemodialysis PatientsTherapeutic Apheresis and Dialysis, 2009
- Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Vitamin D levels and patient outcome in chronic kidney diseaseKidney International, 2009
- Vitamin D and Human Health: Lessons from Vitamin D Receptor Null MiceEndocrine Reviews, 2008
- Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort studyThe American Journal of Clinical Nutrition, 2008
- Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney diseaseClinical and Experimental Nephrology, 2008
- Vitamin D levels and early mortality among incident hemodialysis patientsKidney International, 2007
- Vitamin D DeficiencyNew England Journal of Medicine, 2007